Title | Journal | Journal Categories | Citations | Publication Date |
---|---|---|---|---|
Recent advances in induced proximity modalities | Current Opinion in Chemical Biology |
| 10 | 2022 |
PROTAC targeted protein degraders: the past is prologue | Nature Reviews Drug Discovery |
| 880 | 2022 |
Multiple cereblon genetic changes are associated with acquired resistance to lenalidomide or pomalidomide in multiple myeloma | Blood Journal |
| 78 | 2021 |
The PROTACtable genome | Nature Reviews Drug Discovery |
| 100 | 2021 |
Cancer therapies based on targeted protein degradation — lessons learned with lenalidomide | Nature Reviews Clinical Oncology |
| 61 | 2021 |